TTrialPathMatch Me to Trials
← Back to trials
RecruitingType 2 DiabetesOverweight and Obesity

Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes

Eligible age

30–55 yrs

Accepts

All genders

Locations

2 states

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this two-site grant proposal is to determine the role of the decreased insulin-mediated muscle perfusion found in type 2 diabetes in contributing to the development of cardiac and skeletal muscle dysfunction and subsequent functional exercise impairment. In addition, it is also our goal to determine whether exercise training attenuates insulin resistance and restores insulin-mediated perfusion to the heart and to skeletal muscle, leading to improved cardiac function and exercise performance.

Sponsor: University of Colorado, Denver

You may qualify if…

  • Sedentary (defined as less than 1 hour per week of physical activity)
  • BMI: 25-40
  • Men and women with and without type 2 diabetes

You may not qualify if…

  • Documented cardiovascular disease
  • Uncontrolled hypertension: disease systolic blood pressure (SBP) \> 150, diastolic blood pressure (DBP)\> 110
  • Obstructive pulmonary disease or asthma
  • Peripheral neuropathy
  • Physical impairment that would limit exercise ability
  • Subjects taking beta blockers, calcium channel blockers, insulin, or Thiazolidinediones (TZD)
  • Current or past smoking within the last 1 years
  • Current tobacco use

Where it's recruiting

Colorado

Aurora

Virginia

Charlottesville

Source: ClinicalTrials.gov · NCT04791371 · last updated 2026-03-23

Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness · TrialPath